TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 31, 2014
TCL Archive Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation August 29, 2014
TCL Archive Guest Editorial: Omics Checklist Done, Now Create Business Model For Tests February 7, 2013
TCL Archive Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors. June 10, 2005
